摘要
Muscle & NerveVolume 44, Issue 1 p. 4-5 Editorial What does body mass index measure in amyotrophic lateral sclerosis and why should we care? Edward J. Kasarskis MD, PhD, Corresponding Author Edward J. Kasarskis MD, PhD [email protected] Department of Neurology, University of Kentucky, Lexington, Kentucky 40536-0284, USADepartment of Neurology, University of Kentucky, Lexington, Kentucky 40536-0284, USASearch for more papers by this author Edward J. Kasarskis MD, PhD, Corresponding Author Edward J. Kasarskis MD, PhD [email protected] Department of Neurology, University of Kentucky, Lexington, Kentucky 40536-0284, USADepartment of Neurology, University of Kentucky, Lexington, Kentucky 40536-0284, USASearch for more papers by this author First published: 31 March 2011 https://doi.org/10.1002/mus.22113Citations: 5Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1 Dupuis L, Pradat PF, Ludolph AC, Loeffler JP. Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol 2011; 10: 75–82. 10.1016/S1474-4422(10)70224-6 CASPubMedWeb of Science®Google Scholar 2 Paganoni S, Deng J, Jaffa M, Cudkowicz ME, Wills A-M. Body mass index, not dyslipidemia, is an independent predictor of survival in ALS. Muscle Nerve (in press). Google Scholar 3 Dorst J, Kühnlein P, Hendrich C, Kassubek J, Sperfeld AD, Ludolph AC. Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis. J Neurol 2010; 258: 613–617. 10.1007/s00415-010-5805-z CASPubMedWeb of Science®Google Scholar 4 Dupuis L, Corcia P, Fergani A, Gonzalez De Aguilar JL, Bonnefont-Rousselot D, et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology 2008; 70: 1004–1009. 10.1212/01.wnl.0000285080.70324.27 CASPubMedWeb of Science®Google Scholar 5 Miller RG, Rosenberg JA, Gelinas DF, Mitsumoto H, Newman D, Sufit R, et al. Practice parameter: The care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS practice parameters task force. Neurology 1999; 52: 1311–1323. 10.1212/WNL.52.7.1311 CASPubMedWeb of Science®Google Scholar 6 Miller RG, Anderson F, Brooks BR, Mitsumoto H, Bradley WG, Ringel SP. Outcomes research in amyotrophic lateral sclerosis: lessons learned from the amyotrophic lateral sclerosis clinical assessment, research, and education database. Ann Neurol 2009; 65( suppl 1): S24–S28. 10.1002/ana.21556 PubMedWeb of Science®Google Scholar 7 Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, et al. Practice parameter update: The care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009; 73: 1218–1226. 10.1212/WNL.0b013e3181bc0141 CASPubMedWeb of Science®Google Scholar 8 Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, et al. Practice parameter update: The care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009; 73: 1227–1233. 10.1212/WNL.0b013e3181bc01a4 CASPubMedWeb of Science®Google Scholar Citing Literature Volume44, Issue1July 2011Pages 4-5 ReferencesRelatedInformation